Patent ReferencesComposition Method and composition for treating and preventing irritation of the mucous membranes of the nose Aerosol foam Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion Decongestant Patent #: 4826683 InventorAssigneeApplicationNo. 576021 filed on 08/31/1990US Classes:514/783, Plant extract or plant material of undetermined constitution514/974CONTAINING DESIGNATED INGREDIENT TO REDUCE NOXIOUS EFFECTS OF ACTIVE INGREDIENT (E.G., TASTE MASKING, ODOR REDUCING, ETC.)ExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmInternational ClassesA61K 009/08A61K 047/00 AbstractAn aqueous, flavored, topical, nasal decongestant composition containing an amount of oxymetazoline or a pharmaceutically acceptable salt thereof e.g., oxymetazoline HCl sufficient to effect nasal decongestion and an amount of a fruity flavor e.g. cherry flavor, sufficient to mask the medicinal after-taste of the composition, together with an aqueous carrier.Other References
| |